Roller coaster for Valneva’s inactivated Covid-19 vaccine
Valneva SE announced that the United Arab Emirates (UAE) granted emergency use authorization for its inactivated, adjuvanted COVID-19 vaccine, VLA2001. […]
Valneva: Positive Phase 3 Results for COVID-19 Vaccine
Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001 that successfully met both co-primary endpoints. Superior neutralizing antibody titer levels compared to active comparator vaccine, AstraZeneca’s AZD1222 (ChAdOx1-S). Neutralizing antibody seroconversion [...]